- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01786863
Frequency of Residual Neuromuscular Blockade in the Pediatric Population
November 30, 2016 updated by: Hiromi Kako, Nationwide Children's Hospital
This study is designed to investigate the frequency of Residual Neuromuscular Blockade (RNMB) in the pediatric population.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Detailed Description
The proposed study will be the first to investigate the incidence of residual postoperative neuromuscular blockade in the pediatric patient following the intraoperative use of NMBA's.
If there is significant residual blockade present, it may be that these effects will lead to postoperative respiratory complications including hypoxemia, atelectasis, and prolonged oxygen requirement resulting in a prolonged stay in the post-anesthesia care unit.
Study Type
Observational
Enrollment (Actual)
5
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ohio
-
Columbus, Ohio, United States, 43205
- Nationwide Children's
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 17 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients undergoing surgery that requires them to be paralyzed
Description
Inclusion Criteria:
- Age less than 18 years.
- Surgery requiring the administration of neuromuscular blocking, agents with planned extubation in the postoperative care unit (PACU).
Exclusion Criteria:
- Neuromuscular diseases which may prolong the duration of NMBA's or exaggerate the effects of residual blockade.
- The need for postoperative mechanical ventilation.
- Direct admission to the Pediatric ICU, NICU or CTICU.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Neuromuscular blockade
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
train-of-four (TOF) ratio
Time Frame: 1 day
|
TOF ratio shows the residual of neuromuscular agents.
|
1 day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2013
Primary Completion (Actual)
December 1, 2015
Study Completion (Actual)
December 1, 2015
Study Registration Dates
First Submitted
February 6, 2013
First Submitted That Met QC Criteria
February 6, 2013
First Posted (Estimate)
February 8, 2013
Study Record Updates
Last Update Posted (Estimate)
December 2, 2016
Last Update Submitted That Met QC Criteria
November 30, 2016
Last Verified
November 1, 2016
More Information
Terms related to this study
Other Study ID Numbers
- IRB13-00045
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neuromuscular Blockade
-
Seoul National University Bundang HospitalCompletedNeuromuscular Blockade | Neuromuscular Blockade MonitoringSouth Korea
-
Hospital Federal de BonsucessoUnknownNeuromuscular Blockade | Magnesium Sulfate | Rocuronium | Deep Neuromuscular BlockadeBrazil
-
Universitair Ziekenhuis BrusselCompletedNeuromuscular Blockade | Neuromuscular MonitoringBelgium
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...CompletedNeuromuscular Blockade | Neuromuscular MonitoringItaly
-
University Hospital of PatrasNot yet recruitingNeuromuscular Blockade
-
The Fourth Affiliated Hospital of Zhejiang University...RecruitingNeuromuscular BlockadeChina
-
Ciusss de L'Est de l'Île de MontréalRecruiting
-
University Hospital UlmNot yet recruitingNeuromuscular Blockade
-
Christoph CzarnetzkiOspedale Regionale di Lugano; Centre Hospitalier du Centre du ValaisRecruiting
-
Jiangsu HengRui Medicine Co., Ltd.CompletedNeuromuscular BlockadeChina
Clinical Trials on Neuromuscular blockade
-
Kyung Hee University Hospital at GangdongMerck Sharp & Dohme LLCCompletedThoracic Surgery | One-lung VentilationKorea, Republic of
-
Tamas Vegh, MDSenzime ABCompletedNeuromuscular BlockadeHungary
-
Menoufia UniversityRecruitingPain Scores | Change in Serum Levels of the Estimated Inflammatory Cytokines | Total Dose of IO Fentanyl | PO Morphine | Surgeons' RatingEgypt
-
Ohio State UniversityRecruitingGastrointestinal Dysfunction | Postoperative IleusUnited States
-
Radboud University Medical CenterMerck Sharp & Dohme LLCUnknown
-
Seoul National University Bundang HospitalCompletedNeuromuscular Blockade | Neuromuscular Blockade MonitoringSouth Korea
-
Erasme University HospitalCompletedCardiac Surgery | Neuromuscular Blocking AgentsBelgium
-
Brno University HospitalCompletedMuscle RelaxationCzechia
-
Università Vita-Salute San RaffaeleTerminatedNeuromuscular Blockade | Hepatic Cancer | Intraoperative BleedingItaly
-
Seoul National University Bundang HospitalUnknown